24 October 2023
Cancers | Most Viewed Special Issues in 2023 in the Section “Cancer Drug Development”


We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Drug Development”. The Special Issues list is as follows:

Advances in Anticancer Drugs and Pharmacotherapy of Cancer
Edited by Dr. Muhammad Abdul Hadi, Dr. Md. Sanower Hossain and Dr. Bey-Hing Goh
Views: 35600+ times

Measurable Residual Disease in Cancer
Edited by Prof. Dr. Krzysztof Jamroziak and Dr. Bartosz Pula
Views: 11800+ times

Drug Resistance in Gastrointestinal Cancer
Edited by Dr. Rosalba D’Alessandro and Dr. Carmelo Ferrai
Views: 5500+ times

Molecular Mechanisms of Anti-cancer Drugs Action
Edited by Dr. Barbara Pucelik
Views: 4700+ times

Advanced Cancer Nanotheranostics
Edited by Prof. Dr. Marco Filice
Views: 1200+ times

Cancer Cell Metabolism and Drug Targets
Edited by Dr. Daniel S. Sitar and Prof. Dr. Donald Miller
Views: 730+ times

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

Back to TopTop